cell

(redirected from giant cell)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.

cell

an independent team of operatives who work together in a CELLULAR MANUFACTURING production environment.
References in periodicals archive ?
Specialty pharmacy Biologics by McKesson reported on Wednesday that it has been selected by Daiichi Sankyo Inc as the exclusive specialty pharmacy provider for TURALIO (pexidartinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) with severe morbidity or functional limitations and not amenable to improvement with surgery.
In a large study of almost 40, 000 adult patients with polymyalgia rheumatica or giant cell arteritis in England, researchers found higher absolute risks of infection when patients were taking oral steroids than when they were not taking them.
WHO 2010 sets undifferentiated carcinoma with osteoclast-like giant cell and pleomorphic giant cell as a pancreatic ductal adenocarcinoma variant, although UCOGC is a tumor with a much better prognosis [16].
Keywords: Fetomaternal barrier, Ferrous sulphate, Gestation day, Giant cells, Labyrinthine zone, Trophospongium zone.
Aggressive central giant cell granuloma of the mandible, a diagnostic dilemma.
Postoperative histopathologic analysis revealed a benign giant cell lesion.
Herein, we report two cases of confirmed giant cell arteritis (GCA) which were complicated with small intestinal damage associated with prolonged NSAIDs use that mislead the clinicians to other FUO etiologies.
According to previous reports, giant cell formation is observed in more than two-thirds of the parenchyma and is most pronounced in zone 3.
Giant cell tumor of soft tissue (GCTST) is a rare lesion that has sporadically been reported in the literature as far back as the early 19th century [1, 2].
Among IDHwildtype tumors, the WHO recognizes giant cell glioblastoma, gliosarcoma, and epithelioid glioblastoma [1].
The regimen used to treat giant cell tumor (GCT) was implemented which consisted of subcutaneous denosumab (120 mg) given every 4 weeks (with additional 120 mg SC doses on days 8 and 15 in cycle 1 only) for a total of 12 months [12].